Literature DB >> 25032207

Optimal management of a patient with recurrent nasopharyngeal carcinoma.

Francesco Perri1, Italo Dell'Oca1, Paolo Muto1, Concetta Schiavone1, Corrado Aversa1, Franco Fulciniti1, Raffaele Solla1, Giuseppina Della Vittoria Scarpati1, Carlo Buonerba1, Giuseppe Di Lorenzo1, Francesco Caponigro1.   

Abstract

Nasopharyngeal carcinoma is rare in western countries, accounting for less than 1% of all malignancies. Despite prognosis is satisfactory for newly diagnosed, non-metastatic disease, management of recurrent disease is challenging, with a survival expectancy of approximately 6 mo with the use of chemotherapy as the sole salvage treatment. We report a case of recurrent nasopharyngeal carcinoma treated with a combination of chemotherapy, radiotherapy and surgery in the context of a multidisciplinary approach. A durable complete response was achieved.

Entities:  

Keywords:  Cetuximab; Nasopharyngeal carcinoma; Re-irradiation; Surgery of metastases; Undifferentiated

Year:  2014        PMID： 25032207      PMCID： PMC4097159          DOI： 10.12998/wjcc.v2.i7.297

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN： 2307-8960            Impact factor:   1.337


  10 in total

Review 1.  Treatment approaches to nasopharyngeal carcinoma: a review.

Authors:  Francesco Caponigro; Francesco Longo; Franco Ionna; Francesco Perri
Journal:  Anticancer Drugs       Date:  2010-06       Impact factor: 2.248

2.  Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.

Authors:  J Ma; H Q Mai; M H Hong; H Q Min; Z D Mao; N J Cui; T X Lu; H Y Mo
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

3.  Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.

Authors:  Anthony T C Chan; Mow-Ming Hsu; Boon C Goh; Edwin P Hui; Tsang-Wu Liu; Michael J Millward; Ruey-Long Hong; Jacqueline Whang-Peng; Brigette B Y Ma; Ka F To; Matthias Mueser; Nadia Amellal; Xiao Lin; Alex Y Chang
Journal:  J Clin Oncol       Date:  2005-04-04       Impact factor: 44.544

4.  Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.

Authors:  H Boussen; E Cvitkovic; J L Wendling; N Azli; M Bachouchi; R Mahjoubi; C Kalifa; P Wibault; G Schwaab; J P Armand
Journal:  J Clin Oncol       Date:  1991-09       Impact factor: 44.544

Review 5.  How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?

Authors:  P M Teo; W H Kwan; A T Chan; W Y Lee; W W King; C O Mok
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-03-01       Impact factor: 7.038

6.  Locally advanced nasopharyngeal carcinoma: Current and emerging treatment strategies.

Authors:  Francesco Perri; Davide Bosso; Carlo Buonerba; Giuseppe Di Lorenzo; Giuseppina Della Vittoria Scarpati
Journal:  World J Clin Oncol       Date:  2011-12-10

7.  Induction docetaxel-cisplatin followed by extended-field radiotherapy in patients with cervical metastases from unknown primary carcinoma.

Authors:  Francesco Perri; Franco Ionna; Paolo Muto; Carlo Buonerba; Giuseppina Della Vittoria Scarpati; Davide Bosso; Franco Fulciniti; Antonio Daponte; Angela Argenone; Fabio Sandomenico; Giuseppe DI Lorenzo; Francesco Caponigro
Journal:  Anticancer Res       Date:  2013-03       Impact factor: 2.480

8.  Recurrent nasopharyngeal carcinoma: current management approaches.

Authors:  Robert I Smee; Nicola S Meagher; Kathryn Broadley; Timothy Ho; Janet R Williams; G Patrick Bridger
Journal:  Am J Clin Oncol       Date:  2010-10       Impact factor: 2.339

9.  Integrated therapeutic approaches in head and neck cancer: the importance of multidisciplinary team management.

Authors:  Francesco Perri; Paolo Muto; Corrado Aversa; Antonio Daponte; Giuseppina Della Vittoria; Stefano Pepe; Francesco Caponigro
Journal:  Anticancer Agents Med Chem       Date:  2013-07-01       Impact factor: 2.505

10.  Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer.

Authors:  Falk Roeder; Felix Zwicker; Ladan Saleh-Ebrahimi; Carmen Timke; Christian Thieke; Marc Bischof; Juergen Debus; Peter E Huber
Journal:  Radiat Oncol       Date:  2011-03-01       Impact factor: 3.481
  10 in total
  5 in total

1.  Clinicopathological significance of ROCK1 and PIK3CA expression in nasopharyngeal carcinoma.

Authors:  Xuanyi Wang; Yuxiang Huang; Renhua Guo; Yongbiao Liu; Yayun Qian; Dan Liu; Xiaojun Dai; Zheng Wei; Feng Jin; Yanqing Liu
Journal:  Exp Ther Med       Date:  2017-01-23       Impact factor: 2.447

2.  Identification of long non-coding RNA CCAT1 as an oncogene in nasopharyngeal carcinoma.

Authors:  Yameng Dong; Haozhan Yuan; Guangyu Jin
Journal:  Oncol Lett       Date:  2018-06-13       Impact factor: 2.967

3.  Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy in Saudi Arabia.

Authors:  Ahmed Marzouk Maklad; Yasser Bayoumi; Mohamed Abdalazez Senosy Hassan; AbuSaleh A Elawadi; Hussain AlHussain; Ashraf Elyamany; Saleh F Aldhahri; Khalid Hussain Al-Qahtani; Mubarak AlQahtani; Mutahir A Tunio
Journal:  Onco Targets Ther       Date:  2016-10-25       Impact factor: 4.147

4.  Long non-coding RNA LUADT1 promotes nasopharyngeal carcinoma cell proliferation and invasion by downregulating miR-1207-5p.

Authors:  Ning Jiang; Lijun Zhao; Dan Zong; Li Yin; Lirong Wu; Cheng Chen; Xue Song; Qian Zhang; Xuesong Jiang; Xia He; Jifeng Feng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  High Expression of FGFR4 Enhances Tumor Growth and Metastasis in Nasopharyngeal Carcinoma.

Authors:  Si Shi; Xingyu Li; Bo You; Ying Shan; Xiaolei Cao; Yiwen You
Journal:  J Cancer       Date:  2015-10-20       Impact factor: 4.207
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.